FDA Approved: ICATIBANT — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for icatibant from Teva Pharmaceuticals USA, Inc. The action updates or adds to the existing labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

SUPPL AP for ICATIBANT (ICATIBANT)